Wednesday, July 22, 2009

Investorideas.com Weekly Top 10 Inbound Searches for Week of July 20th include Natural Gas Stocks, Water Stocks, Renewable Energy Stocks, and Gold Mining Stocks

POINT ROBERTS, Wash., Delta, B.C.–July 22 , 2009 - www.InvestorIdeas.com, a global investor research portal, and one of the first online investor resources providing in-depth information on renewable energy and water, natural gas stocks and other sectors announces this weeks top ten search phrases from inbound investors .

The Top 10 List is featured on Investorideas.com home page and is updated each Wednesday for investors.

1. Natural gas stocks
2. Natural gas companies 3. Water stocks 4. Natural gas news 5. Renewable energy stocks 6. Indian stock market 7. Green energy companies 8. Renewable energy companies 9. Natural gas producers
10. Gold mining stocks

Investor Ideas members following green stocks can access comprehensive global stock directories in natural gas, renewable energy, water stocks and environment and fuel cell stocks.

Natural Gas Stocks : Research Natural Gas stocks
Water Stocks Directory: Research global water stocks
Renewable Energy Stocks Directory: Research global renewable energy stocks
Mining Stocks Directory : Research Mining Stocks

As an added bonus, members can access biotech stocks directory, defense stocks directory, as well as the Insiders Corner by Michael Brush.
“The Insiders Corner “http://www.investorideas.com/insiderscorner/ By Michael Brush is also an Investorideas.com members only feature. Michael Brush writes a weekly market column for MSN Money. Mr. Brush has also covered business and investing for the New York Times, Money magazine and the Economist Group.

Other Green Investor Resources and Tools:

Subscribe to the Renewable Energy and GreenTech Business and Stock News RSS Feed:
http://www.investorideas.com/RSS/feeds/RES.xml

Solar Stocks Commentary with J Peter Lynch: http://www.renewableenergystocks.com/PL/

Investorideas.com Green Investor Audio Series
http://www.investorideas.com/gi/

Investing In Water Podcast: http://www.investorideas.com/ws/
The investing in water podcast features audio interview with some of the sector’s leading experts and fund managers.

Investorideas.com Members- access to green stock directories and trading trends
With markets and investor sentiment changing daily- it is more important than ever to stay on top of key trends! Gain Exclusive Insight on Leading Sectors, Global Trends, and Insider Trading Ideas, News, Articles and Investor Ideas Members only Restricted Content including the water stocks directory, environment stocks and renewable energy stocks directory.
Become an InvestorIdeas.com Member -http://www.investorideas.com/membership/


About InvestorIdeas.com:
Investor Ideas is a global financial media online destination specialized in sector investing content. Investor Ideas (and portals within the hub) was one of the first online investing and business resources providing in-depth information, news and stock directories in renewable energy, homeland security and water sectors. InvestorIdeas.com features over twenty industry sectors and global markets including China, India, Middle East and Australia.

Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp

For Additional Information:

Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com

Source – Investorideas.com

Monday, July 20, 2009

Biotech/Pharma Stocks Sector Close- Up- Human Genome Sciences (NASDAQ:HGSI) up over 200%


POINT ROBERTS, Wash., July 20, 2009 www.BiotechIndustryStocks.com, a global investor website for the biotechnology sector within Investorideas.com, presents a biotech stocks sector close- up following sharp gains from Human Genome Sciences (NASDAQ:HGSI).

Biotech Stock News - Human Genome Sciences (NASDAQ:HGSI) and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus

BENLYSTA (Belimumab) Met Its Primary Efficacy Endpoint by Achieving a Statistically Significant Improvement in Patient Response Rate Versus Placebo in BLISS-52; First Drug for Lupus to Reach This Advanced Stage of Clinical Development and Achieve Positive Results, in the Largest Randomized Placebo-Controlled Clinical Trial Ever Completed in SLE Patients

Human Genome Sciences, Inc. (NASDAQ:HGSI) and GlaxoSmithKline PLC (GSK) - July 20, 2009 -today announced that BENLYSTA(TM) (belimumab, formerly LymphoStat-B?) met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus (SLE). In the placebo-controlled BLISS-52 study, the results showed that BENLYSTA plus standard of care achieved a clinically and statistically significant improvement in patient response rate at Week 52, compared with standard of care alone. Study results also showed that belimumab was generally well tolerated, with adverse event rates comparable between belimumab and placebo treatment groups.
Read full story

Investors can learn how to invest in and trade Biotech/Pharm Stocks with our Biotech Stocks Directory (Includes Stem Cell Stocks), Medical Stocks, Life Sciences and Pharma Stocks at Biotechindustrystocks.com and Investorideas.com

Biotech Stocks Directory Preview:
3SBio Inc. (NasdaqGS:SSRX) 3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China.

Aastrom Biosciences, Inc. (NasdaqCM: ASTM) Aastrom is a leader in the development of autologous cell products for the repair or regeneration of human tissue. The Company's proprietary Tissue Repair Cell (TRC) technology involves the use of a patient's own cells to manufacture products to treat a range of chronic diseases and serious injuries. Aastrom's TRC-based products contain increased numbers of stem and early progenitor cells, produced from a small amount of bone marrow collected from the patient. The TRC technology platform has positioned Aastrom to advance multiple products into clinical development. Ongoing development activities are focused on applications of the technology to cardiac and vascular regeneration. The Company currently has a cardiovascular regeneration product in Phase II development for the treatment of dilated cardiomyopathy (DCM) (called the IMPACT-DCM trial) and critical limb ischemia (called the RESTORE-CLI trial).

ABAXIS, Inc. (NasdaqGS: ABAX) Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.

ABBOTT LABORATORIES (NYSE: ABT) Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 68,000 people and markets its products in more than 130 countries.

ABIOMED INC (NasdaqGM:ABMD) Based in Danvers, Massachusetts, Abiomed, Inc., is a leading provider of medical devices that provide circulatory support to acute heart failure patients across the continuum of care in heart recovery. Our products are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping of the heart.

Acadia Pharmaceuticals Inc. (NasdaqGM: ACAD) ACADIA is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACADIA is focused on developing a portfolio of its four most advanced product candidates, including pimavanserin in Phase III for Parkinson's disease psychosis, a product candidate in Phase II for chronic pain and a product candidate in Phase I for glaucoma, both in collaboration with Allergan, and ACP-106 in IND-track development. All of the product candidates in ACADIA's pipeline emanate from discoveries made using its proprietary drug discovery platform.

ACAMBIS PLC ADS (OTCPK:ACAMY) Acambis is a vaccine company developing novel vaccines that address significant unmet medical needs or substantially improve upon current standards of care.

Accentia Biopharmaceuticals, Inc. (OTCPK:ABPIQ) Accentia Biopharmaceuticals, Inc. (Other OTC: ABPI) is committed to building significant value for its stockholders through the commercialization of patent-protected disruptive healthcare technologies designed to be positioned as leading products for the treatment of a broad range of chronic, debilitating and life-threatening diseases including respiratory, autoimmune and cancer indications.

Acorda Therapeutics, Inc. (NasdaqGM:ACOR) Acorda Therapeutics is a biotechnology company developing therapies for spinal cord injury, multiple sclerosis and related nervous system disorders. The Company's marketed products include Zanaflex Capsules® (tizanidine hydrochloride), a short-acting drug for the management of spasticity. The Company's pipeline includes a number of products in development for the treatment, regeneration and repair of the spinal cord and brain.

Acrongenomics, Inc. (OTCBB: AGNM) Acrongenomics Inc. is a publicly traded company that focuses on investing in and commercializing novel technology platforms concerning the Life Sciences sector. Acrongenomics brings novel and realistic concepts to market by transforming scientific innovations into tangible, consumer-orientated applications. The company has its headquarters in London, England

About Biotechindustrystocks.com:
BiotechIndustryStocks.com is a global meeting place for investors and industry following the biotech sector, within Investorideas.com. Global visitors use the site daily to research the latest biotech stock and industry news, articles, audio, research reports and our stock directories.

Biotech services for investors and publicly traded companies:

Visit the Biotech/Pharma Stock Directory

Biotech public and private companies can submit news releases and press releases : Submit Press Releases

Become a Biotech Showcase company on Investorideas.com and Biotechindustrystocks.com

Submit Your Biotech company profile

About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing covering over thirty industry sectors and global markets including China, India, the Middle East and Australia.

Investorideas.com Membership – Access full Biotech Stocks Directory, water stocks and more…
With markets and investor sentiment changing daily- it is more important than ever to stay on top of key trends! Gain Exclusive Insight on Leading Sectors, Global Trends, and Insider Trading Ideas, News, Articles and Investor Ideas Members only Restricted Content including the complete renewable energy stocks directory, water stocks, biotech and defense stocks directory, as well as the Insiders Corner by Michael Brush.
Become an InvestorIdeas.com Member

InvestorIdeas.com Disclaimer: www.InvestorIdeas.com/About/Disclaimer.asp
Our sites do not make recommendations, but offer information portals to investors to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of any information presented. All information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is compensated by featured companies, news submissions and online advertising.

For more information contact:
Dawn Van Zant 800.665.0411 dvanzant@investorideas.com
Or cvanzant@investorideas.com

Saturday, July 11, 2009

Investor Ideas - Stock Picking/Trading Contest

Highest gainer each week wins Investor Ideas Premium Offers - Including Our Investor Ideas Annual Membership

- www.InvestorIdeas.com, a leading investor research portal specialized in sector investing announces its new investor contest, for investors traders following leading sectors including renewable energy, water, tech, biotech and more.

Investor Ideas asks traders - “Do you know the stock market? Sign up with your weekly stock pick by name, ticker and sector and tell us why it’s your pick of the week.
http://www.investorideas.com/membership/contest.asp

Send Investor Ideas your favorite stock pick within one of the specific sectors that it covers (Cleantech, Environment, China-Asia, India, Technology, Digital Media, Homebuilder, Natural Gas, Coal, Mining, Defense, Water, Oil and Gas, etc). see full list * http://www.investorideas.com/dirs/stocklist.asp

Investors get the chance to win prizes including premium memberships at Investorideas.com.

Learn more about the contest:
http://www.investorideas.com/membership/contest.asp


Prizes:
Green Funding Directory (Value $99.00) - Get Funded
Company Profile (Public company or private company – promote your business) (Value: $99)
Investor Ideas Membership- Value $99
Investorideas.com membership gives full login access to the Water Stocks Directory, Renewable Energy Stocks Directory , Environment Stocks, Fuel cell Stocks, Natural Gas Stocks, Biotech Stocks Directory , Defense Stocks Directory and the Insiders Corner Investing Stock Newsletter.
Learn more about InvestorIdeas.com membership: http://www.investorideas.com/membership/

Sponsorship Opportunities –
Companies offering investor trading services and tools that would like information on sponsoring the contest, please contact us below.

About InvestorIdeas.com:
Investorideas.com creates a meeting place for investing ideas to take form and come to life in an entrepreneurial environment, servicing the needs of small investors and start- up companies to large conglomerates! We cover multiple industry sectors but specialize in environmental and water.

Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp

For Additional Information:

Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com

Source – Investorideas.com

Wednesday, July 01, 2009

Treasury Awards $8 Million in Recovery Act Funding for Native Communities

At Event on the Pine Ridge Indian Reservation, CDFI Fund Director Gambrell Announces Awards for Native Community Development Financial Institutions

July 1, 2009
Kyle, SD - As part of the Obama Administration's continued investment in economic development in communities around the country through the Recovery Act, Treasury's Community Development Financial Institutions (CDFI) Fund Director Donna J. Gambrell today announced $8 million in financial assistance awards for 10 CDFIs committed to serving economically distressed Native American, Alaska Native, and Native Hawaiian communities across the nation.

"These Native CDFIs are transforming their communities by helping to create businesses and needed jobs, provide affordable housing and build vital community facilities in places that desperately need them. They are providing personal financial education and developing business skills in communities that have been excluded from our nation's economic mainstream and they are helping to change the lives of the people they serve," said Gambrell. "In addition to the Recovery Act awards announced today, I'm pleased to announce that the CDFI Fund is releasing a new Native Initiatives five-year strategic plan reaffirming our commitment to overcoming the barriers to capital within Native communities."


The event was hosted by The Lakota Funds, a Treasury certified Native CDFI that provides microloans, small business loans, and business training and technical assistance to members of the Oglala Sioux Nation living on the Pine Ridge Indian Reservation. The announcement was held at the Lakota Trade Center, a 13,000 square foot building supported by The Lakota Funds that provides prime office space for reservation businesses and programs. The center has given rise to The Lakota Funds' award-winning Wawókiye Business Institute that provides entrepreneurs with training and a support network of local, regional, and national business experts.


Also announced at the event were the names of the 26 Native institutions selected from across the nation to receive an aggregate total of $3.3 million in technical assistance grants under the Native American CDFI Assistance Program made possible through the CDFI Fund's FY 2009 annual appropriations.


Recognized at the event were five South Dakota-based award recipients: First Nations Oweesta Corporation (Rapid City); Mazaska Owecaso Otipi Financial, Inc. (Pine Ridge); The Lakota Funds (Kyle); Four Bands Community Fund, Inc. (Eagle Butte); and The Harvest Initiative, Inc. (Fort Thompson) – all of which are leaders serving the community development needs of their Native communities.

The awardees were selected after a competitive review of 49 applications received by the CDFI Fund from organizations across the nation that requested $16.5 million in funding under the 2009 round of the NACA Program.


The CDFI Fund's Native Initiatives work to increase access to credit, capital, and financial services in communities by creating and expanding CDFIs primarily serving Native communities. This is achieved by funding programs and providing a series of training programs to organizations working in Native areas. The CDFI Fund's Native Initiatives also makes financial assistance awards to certified Native CDFIs and provides grants to Native organizations to help them build the capacity to become a certified Native CDFI.


For more information about these awards, or about the CDFI Fund and its programs, please visit the Fund's website at: http://www.cdfifund.gov.